Equity incl. NCI
Balance – as of period end · $M
FY2025
1,364$M
All values (5)
| Period | Value ($M) | Status |
|---|---|---|
| FY2025 | 1,364 | reported |
| FY2024 | 965 | reported |
| FY2023 | −98 | reported |
| FY2022 | −85 | reported |
| FY2021 | −40 | reported |
| FY2016 – FY2020 | – | missing (5 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $1.4B
- Period
- FY2025, ended Dec 31, 2025 · as of Dec 31, 2025 (balance as of date, not a sum)
- Source
- 10-K, filed Feb 20, 2026 · 0001736297-26-000010
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $1.4B | Feb 20, 2026 | 10-K 0001736297-26-000010 | reported · confidence 1. · current |